Literature DB >> 32916243

The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus.

Sheng-Ling Leng1, Rong Huang1, Ya-Nan Feng1, Li-Juan Peng1, Jian Yang2, Yu-Hua Li3.   

Abstract

After sequence comparison, it was found that there are multiple amino acid mutations in pre-M and envelope (E) protein of Japanese encephalitis virus vaccine strain comparison with wild type (WT) strain SA14. It is generally acknowledged it is the mutations that have caused the virulence attenuation of vaccine strain, but lack of sufficient experimental evidences. For a better understanding of the mechanism of attenuation of Japanese encephalitis virus (JEV), in this study, we assessed whether prM/E is critical neurovirulence determinants of JEV with infectious cDNA clones technique. Substitutions prM/E of vaccine strain with that of WT SA14 did significantly increase the virulence of JEV to the similar level of wild type SA14, and simultaneously, replacement prM/E of JEV WT strain SA14 with that of vaccine strain SA14-14-2 decreased the virulence of JEV significantly to the similar level of vaccine stain. The results indicate that the prM/E protein is the crucial virulence determinant of Japanese encephalitis virus, although other proteins take part in the process to some extent.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Infectious cDNA clones; Japanese encephalitis virus; Virulence

Mesh:

Substances:

Year:  2020        PMID: 32916243     DOI: 10.1016/j.micpath.2020.104492

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  2 in total

1.  Development and characterization of an animal model of Japanese encephalitis virus infection in adolescent C57BL/6 mouse.

Authors:  Aarti Tripathi; Arup Banerjee; Sudhanshu Vrati
Journal:  Dis Model Mech       Date:  2021-10-22       Impact factor: 5.758

2.  Genomic Characteristics and E Protein Bioinformatics Analysis of JEV Isolates from South China from 2011 to 2018.

Authors:  Yawei Sun; Hongxing Ding; Feifan Zhao; Quanhui Yan; Yuwan Li; Xinni Niu; Weijun Zeng; Keke Wu; Bing Ling; Shuangqi Fan; Mingqiu Zhao; Lin Yi; Jinding Chen
Journal:  Vaccines (Basel)       Date:  2022-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.